Folitrax (50 mg) Injection Side Effects and usage
Read about what are the Folitrax (50 mg) Injection medicine side effects, how and when to use Folitrax (50 mg) Injection, common indications of Folitrax (50 mg) Injection, when not to use Folitrax (50 mg) Injection (contra indications), manufacturer, price and generic molecules.
Folitrax (50 mg) - Methotrexate- Injection is manufactured by IPCA Laboratories Ltd. and the main constituent generic drug is Methotrexate- 25 mg.
Folitrax (50 mg) Injection Medicine Side effects and usage
Megaloblastic anaemia, pancytopenia, desquamation and bleeding may occur in GIT.
Skin reactions, alopecia, ocular irritation, arachnoiditis in intrathecal use, megaloblastic anaemia, osteoporosis, precipitation of diabetes, arthralgias.
Interstitial lung disease, leukoencephalopathy.
Maintaining remission in children with acute leukaemias.
Autoimmune diseases like rapidly progressing rheumatoid arthritis, severe psoriasis, pemphigus, myasthenia gravis, uveitis, chronic active hepatitis.
Pregnancy and lactation.
Severe renal or hepatic impairment, pre-existing profound bone-marrow suppression.
Early hepatic and renal dysfunction.
Bone marrow depression, elderly, neonates.
Use of folinic acid rescue has permitted much higher doses of methotrexate.
The cost of the drug per 1 ml is Rs.52.5 in India as of date.
Folitrax (50 mg) Injection mainly contains the generic formulation called as Methotrexate- 25 mg.
Folitrax (50 mg) Injection Medicine Generics
Folitrax (50 mg) InjectionManufacturer:
IPCA Laboratories Ltd.Generic Molecule:
Folitrax (50 mg) Injection Similar Medicines List: